FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain

The Wall Street Journal (online registration required): WALTHAM, Mass., Jul 08, 2014 (BUSINESS WIRE) -- NeuroMetrix, Inc. NURO -1.56% today announced that its wearable technology for treatment of chronic pain received 510(k) clearance (K140333) from the U.S. Food and Drug Administration (FDA) for over-the-counter use.

Read article

Tags

Share